CYHB1806626 | 丙戊酸钠口服溶液 | sodium valproate | Oral solution | Chemical Drugs | Supplementary Application | 2019-01-21 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | In Review | 2019-01-18 | view |
CYHB1601536 | 丙戊酸钠口服溶液 | sodium valproate | Oral solution | Chemical Drugs | Supplementary Application | 2016-03-31 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2017-03-01 | view |
CYHB1601932 | 丙戊酸钠缓释片 | sodium valproate | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-07-06 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2018-05-17 | view |
CYHB1601537 | 丙戊酸钠缓释片 | sodium valproate | Tablet, extended release | Chemical Drugs | Supplementary Application | 2016-03-31 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2017-03-01 | view |
CYHB1805446 | 丙戊酸钠缓释片(Ⅰ) | sodium valproate | Tablet, extended release | Chemical Drugs | Supplementary Application | 2018-11-02 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | In Review | 2018-11-01 | view |
JYHB2001552 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2020-08-24 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Filed | 2020-09-01 | view |
JYHF1700098 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2017-10-11 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2017-11-07 | view |
CYHB2100179 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2021-01-25 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | In Review | 2021-01-25 | view |
CYHB1907141 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2020-02-10 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2020-05-26 | view |
CYHB2001420 | 地高辛片 | digoxin | Tablet | Chemical Drugs | Supplementary Application | 2020-04-01 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2020-09-27 | view |
JYHF1700099 | 盐酸屈他维林注射液 | Drotaverine Hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2017-10-20 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2017-11-14 | view |
CYHB1950373 | 盐酸胺碘酮片 | amiodarone hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2019-05-29 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | In Review | 2019-05-28 | view |
CYHB1111294 | 硫酸氢氯吡格雷片 | clopidogrel bisulfate | Tablet | Chemical Drugs | Supplementary Application | 2012-02-13 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2017-09-27 | view |
CYHB2011984 | 硫酸氢氯吡格雷片 | clopidogrel bisulfate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-06 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | In Review | 2021-01-05 | view |
CYHB1800592 | 硫酸氢氯吡格雷片 | clopidogrel bisulfate | Tablet | Chemical Drugs | Supplementary Application | 2018-02-06 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Certificate Issued | 2018-09-03 | view |
CYHB2100223 | 硫酸氢氯吡格雷片 | clopidogrel bisulfate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-06 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | In Review | 2021-02-05 | view |
JYHB2002121 | 硫酸羟氯喹片 | hydroxychloroquine sulfate | Tablet | Chemical Drugs | Supplementary Application | 2020-10-24 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Filed | 2020-11-16 | view |
JYHB2001607 | 碳酸司维拉姆片 | sevelamer carbonate | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | 赛诺菲(杭州)制药有限公司 | Sanofi (Hangzhou) Pharmaceutical Co Ltd | Filed | 2020-09-09 | view |